AstraZeneca CEO doubles down on U.S. amid rumors of listing shift ○
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › July › 29
AstraZeneca
11 months ago
AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was "rapidly transferring manufacturing" across the Atlantic.
European stocks head for higher open; AstraZeneca beats estimates ○
Join CNBC for the latest news on what's moving European markets.
page 1 of 1